to study search History No further version available for comparison

Hypertension Management in Primary Care: "Getting research into practice"

Organizational Data

DRKS-ID:
DRKS00006315
Recruitment Status:
Recruiting complete, study continuing
Date of registration in DRKS:
2014-07-14
Last update in DRKS:
2014-07-14
Registration type:
Retrospective

Acronym/abbreviation of the study

No Entry

URL of the study

No Entry

Brief summary in lay language

Blood pressure control is important to decrease morbidity and mortality, e.g. due to myocardial infarction and stroke. Scientific studies showed that organizational interventions such as patient recall systems and the combination of non-pharmacological treatment with intensified medication increased blood pressure control and decreased mortality. This cluster randomized trial evaluates the effectiveness of a medical education series for primary care physicians about a modern hypertension management on blood pressure control in patients with high blood pressure.

Brief summary in scientific language

Evaluation of the effectiveness of a physician-centered medical education program about hypertension management on blood pressure control of hypertensive patients in primary care.

Health condition or problem studied

ICD10:
I10-I15 - Hypertensive diseases
Healthy volunteers:
No Entry

Interventions, Observational Groups

Arm 1:
Intervention: Evidence-based three-part medical education program for general practitioners on hypertension management; core elements: 1) training on valid upper arm blood pressure readings, 2) evidence-based information on resistant hypertension, secondary hypertension, and modern pharmacotherapy, and 3) introduction and distribution of practice tools to facilitate the long-term implementation of hypertension management.
Arm 2:
Control: Physicians receive the intervention after completion of the follow-up data collection.

Endpoints

Primary outcome:
Blood pressure control rate measured by 24-hour blood pressure readings (blood pressure is measured before the intervention and three months after the last medical education session)
Secondary outcome:
Changes in average systolic and diastolic 24-hour blood pressure; implemented practice redesign elements such as patient recall systems, standardized sheets, disease-specific information leaflets, predefined practice procedures for hypertension management.

Study Design

Purpose:
Health care system
Allocation:
Randomized controlled study
Control:
  • Active control (effective treatment of control group)
Phase:
N/A
Study type:
Interventional
Mechanism of allocation concealment:
No Entry
Blinding:
Yes
Assignment:
Parallel
Sequence generation:
No Entry
Who is blinded:
  • Patient/subject

Recruitment

Recruitment Status:
Recruiting complete, study continuing
Reason if recruiting stopped or withdrawn:
No Entry

Recruitment Locations

Recruitment countries:
  • Germany
Number of study centers:
Multicenter study
Recruitment location(s):
  • Doctor's practice NRW

Recruitment period and number of participants

Planned study start date:
No Entry
Actual study start date:
2013-09-26
Planned study completion date:
No Entry
Actual Study Completion Date:
No Entry
Target Sample Size:
100
Final Sample Size:
179

Inclusion Criteria

Sex:
All
Minimum Age:
18 Years
Maximum Age:
no maximum age
Additional Inclusion Criteria:
Hypertension according to international guidelines (office readings ≥140/90 mmHg, 24-hour ambulatory measurement ≥130/80 mmHg, and/or mean home measurements ≥135/85 mmHg based on a one week protocol with at least 2 measurements daily), with and without hypertension-related diseases

Exclusion Criteria

Unable to give informed consent, not able to read and comprehend the German language

Addresses

Primary Sponsor

Address:
Institut für Allgemeinmedizin, Universitätsklinikum Essen, Universität Duisburg-Essen
Prof. Dr. med. Stefan Gesenhues
Hufelandstraße 55
45147 Essen
Germany
Telephone:
0201-877 869-0
Fax:
0201-877-869-20
Contact per E-Mail:
Contact per E-Mail
URL:
No Entry
Investigator Sponsored/Initiated Trial (IST/IIT):
Yes

Contact for Scientific Queries

Address:
Institut für Allgemeinmedizin, Universitätsklinikum Essen, Universität Duisburg-Essen
Priv.-Doz. Dr. med. Birgitta Weltermann, MPH(USA)
Hufelandstraße 55
45147 Essen
Germany
Telephone:
0201-877 869-0
Fax:
0201-877-869-20
Contact per E-Mail:
Contact per E-Mail
URL:
http://www.uk-essen.de

Contact for Public Queries

Address:
Institut für Allgemeinmedizin, Universitätsklinikum Essen
Priv.-Doz. Dr. med. Birgitta Weltermann, MPH(USA)
Hufelandstraße 55
45147 Essen
Germany
Telephone:
0201-877-86910
Fax:
No Entry
Contact per E-Mail:
Contact per E-Mail
URL:
http://www.uniklinikum-essen.de

Principal Investigator

Address:
Institut für Allgemeinmedizin, Universitätsklinikum Essen, Universität Duisburg-Essen
Priv.-Doz. Dr. med. Birgitta Weltermann, MPH(USA)
Hufelandstraße 55
45147 Essen
Germany
Telephone:
0201-877 869-0
Fax:
0201-877-869-20
Contact per E-Mail:
Contact per E-Mail
URL:
http://www.uk-essen.de

Sources of Monetary or Material Support

Public funding institutions financed by tax money/Government funding body (German Research Foundation (DFG), Federal Ministry of Education and Research (BMBF), etc.)

Address:
Ministerium für Innovation, Wissenschaft und Forschung des Landes Nordrhein-Westfalen
40221 Düsseldorf
Germany
Telephone:
No Entry
Fax:
No Entry
Contact per E-Mail:
Contact per E-Mail
URL:
No Entry

Ethics Committee

Address Ethics Committee

Address:
Ethik-Kommission der Medizinischen Fakultät der Universität Duisburg-Essen
Robert-Koch-Str. 9-11
45147 Essen
Germany
Telephone:
+49-201-7233637
Fax:
+49-201-7235837
Contact per E-Mail:
Contact per E-Mail
URL:
No Entry

Vote of leading Ethics Committee

Vote of leading Ethics Committee
Date of ethics committee application:
2013-07-25
Ethics committee number:
13-5537-BO
Vote of the Ethics Committee:
Approved
Date of the vote:
2013-09-09

Further identification numbers

Other primary registry ID:
No Entry
EudraCT Number:
No Entry
UTN (Universal Trial Number):
No Entry
EUDAMED Number:
No Entry

IPD - Individual Participant Data

Do you plan to make participant-related data (IPD) available to other researchers in an anonymized form?:
No Entry
IPD Sharing Plan:
No Entry

Study protocol and other study documents

Study protocols:
No Entry
Study abstract:
No Entry
Other study documents:
No Entry
Background literature:
No Entry
Related DRKS studies:
No Entry

Publication of study results

Planned publication:
No Entry
Publikationen/Studienergebnisse:
No Entry
Date of first publication of study results:
No Entry
DRKS entry published for the first time with results:
No Entry

Basic reporting

Basic Reporting / Results tables:
No Entry
Brief summary of results:
No Entry